196 related articles for article (PubMed ID: 19351854)
1. Identification of a biphasic role for genistein in the regulation of prostate cancer growth and metastasis.
El Touny LH; Banerjee PP
Cancer Res; 2009 Apr; 69(8):3695-703. PubMed ID: 19351854
[TBL] [Abstract][Full Text] [Related]
2. Dietary genistein improves survival and reduces expression of osteopontin in the prostate of transgenic mice with prostatic adenocarcinoma (TRAMP).
Mentor-Marcel R; Lamartiniere CA; Eltoum IA; Greenberg NM; Elgavish A
J Nutr; 2005 May; 135(5):989-95. PubMed ID: 15867270
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells.
Desai B; Rogers MJ; Chellaiah MA
Mol Cancer; 2007 Mar; 6():18. PubMed ID: 17343740
[TBL] [Abstract][Full Text] [Related]
4. MAPK pathway and SIRT1 are involved in the down-regulation of secreted osteopontin expression by genistein in metastatic cancer cells.
Khongsti K; Das KB; Das B
Life Sci; 2021 Jan; 265():118787. PubMed ID: 33249095
[TBL] [Abstract][Full Text] [Related]
5. Genistein in the diet reduces the incidence of poorly differentiated prostatic adenocarcinoma in transgenic mice (TRAMP).
Mentor-Marcel R; Lamartiniere CA; Eltoum IE; Greenberg NM; Elgavish A
Cancer Res; 2001 Sep; 61(18):6777-82. PubMed ID: 11559550
[TBL] [Abstract][Full Text] [Related]
6. Genistein induces the metastasis suppressor kangai-1 which mediates its anti-invasive effects in TRAMP cancer cells.
El Touny LH; Banerjee PP
Biochem Biophys Res Commun; 2007 Sep; 361(1):169-75. PubMed ID: 17658479
[TBL] [Abstract][Full Text] [Related]
7. Genistein alters growth factor signaling in transgenic prostate model (TRAMP).
Wang J; Eltoum IE; Lamartiniere CA
Mol Cell Endocrinol; 2004 Apr; 219(1-2):171-80. PubMed ID: 15149738
[TBL] [Abstract][Full Text] [Related]
8. Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/MMP-9 signaling in prostate cancer.
Li Y; Kucuk O; Hussain M; Abrams J; Cher ML; Sarkar FH
Cancer Res; 2006 May; 66(9):4816-25. PubMed ID: 16651437
[TBL] [Abstract][Full Text] [Related]
9. MEK4 function, genistein treatment, and invasion of human prostate cancer cells.
Xu L; Ding Y; Catalona WJ; Yang XJ; Anderson WF; Jovanovic B; Wellman K; Killmer J; Huang X; Scheidt KA; Montgomery RB; Bergan RC
J Natl Cancer Inst; 2009 Aug; 101(16):1141-55. PubMed ID: 19638505
[TBL] [Abstract][Full Text] [Related]
10. A short-hairpin RNA targeting osteopontin downregulates MMP-2 and MMP-9 expressions in prostate cancer PC-3 cells.
Liu H; Chen A; Guo F; Yuan L
Cancer Lett; 2010 Sep; 295(1):27-37. PubMed ID: 20207476
[TBL] [Abstract][Full Text] [Related]
11. Dietary genistein inhibits metastasis of human prostate cancer in mice.
Lakshman M; Xu L; Ananthanarayanan V; Cooper J; Takimoto CH; Helenowski I; Pelling JC; Bergan RC
Cancer Res; 2008 Mar; 68(6):2024-32. PubMed ID: 18339885
[TBL] [Abstract][Full Text] [Related]
12. [Effect of short-hairpin RNA expression vector-mediated osteopontin RNA interference on proliferation and invasion of prostate cancer PC-3 cells].
Liu H; Chen AM; Guo FJ; Liao H; Hu WH; Xie J
Chin J Cancer; 2010 Jan; 29(1):43-51. PubMed ID: 20038310
[TBL] [Abstract][Full Text] [Related]
13. Capsaicin reduces the metastatic burden in the transgenic adenocarcinoma of the mouse prostate model.
Venier NA; Yamamoto T; Sugar LM; Adomat H; Fleshner NE; Klotz LH; Venkateswaran V
Prostate; 2015 Sep; 75(12):1300-11. PubMed ID: 26047020
[TBL] [Abstract][Full Text] [Related]
14. Genetic deletion of osteopontin in TRAMP mice skews prostate carcinogenesis from adenocarcinoma to aggressive human-like neuroendocrine cancers.
Mauri G; Jachetti E; Comuzzi B; Dugo M; Arioli I; Miotti S; Sangaletti S; Di Carlo E; Tripodo C; Colombo MP
Oncotarget; 2016 Jan; 7(4):3905-20. PubMed ID: 26700622
[TBL] [Abstract][Full Text] [Related]
15. Genistein increases epidermal growth factor receptor signaling and promotes tumor progression in advanced human prostate cancer.
Nakamura H; Wang Y; Kurita T; Adomat H; Cunha GR; Wang Y
PLoS One; 2011; 6(5):e20034. PubMed ID: 21603581
[TBL] [Abstract][Full Text] [Related]
16. Akt GSK-3 pathway as a target in genistein-induced inhibition of TRAMP prostate cancer progression toward a poorly differentiated phenotype.
El Touny LH; Banerjee PP
Carcinogenesis; 2007 Aug; 28(8):1710-7. PubMed ID: 17468512
[TBL] [Abstract][Full Text] [Related]
17. Identification of both Myt-1 and Wee-1 as necessary mediators of the p21-independent inactivation of the cdc-2/cyclin B1 complex and growth inhibition of TRAMP cancer cells by genistein.
Touny LH; Banerjee PP
Prostate; 2006 Oct; 66(14):1542-55. PubMed ID: 16924665
[TBL] [Abstract][Full Text] [Related]
18. Genistein and resveratrol, alone and in combination, suppress prostate cancer in SV-40 tag rats.
Harper CE; Cook LM; Patel BB; Wang J; Eltoum IA; Arabshahi A; Shirai T; Lamartiniere CA
Prostate; 2009 Nov; 69(15):1668-82. PubMed ID: 19670229
[TBL] [Abstract][Full Text] [Related]
19. Genistein chemoprevention of prostate cancer in TRAMP mice.
Wang J; Eltoum IE; Lamartiniere CA
J Carcinog; 2007 Mar; 6():3. PubMed ID: 17367528
[TBL] [Abstract][Full Text] [Related]
20. Agents used for chemoprevention of prostate cancer may influence PSA secretion independently of cell growth in the LNCaP model of human prostate cancer progression.
Peternac D; Klima I; Cecchini MG; Schwaninger R; Studer UE; Thalmann GN
Prostate; 2008 Sep; 68(12):1307-18. PubMed ID: 18512728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]